Abstract CT237: Evaluation of in vivo chimeric antigen receptor (CAR) transgene levels in patients (pts) treated with tisagenlecleucel
Year: 2019
Type: conference-abstract
Source: Clinical Trials
Authors: Rakesh Awasthi, Karen Thudium Mueller, Gregory A. Yanik, Constantine S. Tam, Susana Rives, Joseph P. McGuirk, Michael A. Pulsipher, Michael W. Boyer, Ulrich Jaeger, Andre Baruchel, Gary D. Myers, Peter Borchmann, Stephen J. Schuster, Heather Stefanski, Michael Bishop, Edward R. Waldron, Ozlem Anak, Abhijit Chakraborty, Eric Bleickardt, Stephane Wong, Lida Bubuteishvili Pacaud, Edmund K. Waller, Shannon L. Maude
Institutions: C. S. Mott Children's Hospital, The University of Melbourne, St Vincent's Hospital Melbourne, Hospital Sant Joan de Déu Barcelona, University of Kansas Medical Center, University of Southern California, Children's Hospital of Los Angeles, University of Utah, Medical University of Vienna, Assistance Publique – Hôpitaux de Paris, Hôpital Robert-Debré, Children's Mercy Hospital, University Hospital Cologne, Abramson Cancer Center, University of Pennsylvania, University of Minnesota, University of Chicago, Novartis (Switzerland), Winship Cancer Institute
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4240639635